OXSORALEN CAP 10MG CAPSULE

País: Canadá

Idioma: inglés

Fuente: Health Canada

Cómpralo ahora

Ficha técnica Ficha técnica (SPC)
17-09-2014

Ingredientes activos:

METHOXSALEN

Disponible desde:

VALEANT CANADA LP / VALEANT CANADA S.E.C.

Código ATC:

D05BA02

Designación común internacional (DCI):

METHOXALEN, SYSTEMIC

Dosis:

10MG

formulario farmacéutico:

CAPSULE

Composición:

METHOXSALEN 10MG

Vía de administración:

ORAL

Unidades en paquete:

100

tipo de receta:

Prescription

Área terapéutica:

PIGMENTING AGENTS

Resumen del producto:

Active ingredient group (AIG) number: 0107802002; AHFS:

Estado de Autorización:

CANCELLED POST MARKET

Fecha de autorización:

2015-08-05

Ficha técnica

                                1
PRESCRIBING INFORMATION
OXSORALEN
10 mg Capsules
(Methoxsalen, USP)
Melanin Repigmentation
Photochemotherapy of Psoriasis and Atopic Dermatitis
Valeant Canada LP
2150 St-Elzear Blvd., West
Laval, Quebec
H7L 4A8
Canada
Date of Preparation: September 27, 2004
Address Updated: September 04, 2014
Control#: 094181
2
PRESCRIBING INFORMATION
OXSORALEN 10 mg CAPSULES
(methoxsalen, USP)
Melanin repigmentation
Photochemotherapy of Psoriasis and Atopic Dermatitis
INDICATIONS
Repigmentation of vitiliginous lesions, to protect against solar
sensitivity and to promote
tanning in persons with very complexion. Oral route is preferred if
extensive repigmentation is
desired since topical application can only be applied to a small area
at a time.
For treatment of psoriasis and atopic dermatitis in combination with
high intensity UVA
light.
CONTRAINDICATIONS
Hepatic insufficiency. Diseases associated with photosensitivity, such
as porphyria, acute
lupus erythematosus or infectious leukoderma. Safety in those 12 years
and under, in aphasic
people, in pregnant women or in women of childbearing age has not been
established. In
albinism it increases tolerance to sunlight, but has no effect on
pigmentation. No preparation
with any photosensitizing capacity, internal or external, should be
used concomitantly with
methoxsalen therapy.
WARNINGS
3
Methoxsalen is a potent drug and it is recommended that the entire
brochure be read
before prescribing or dispensing the information. Safety during
pregnancy or lactation has not
been demonstrated. Use in these conditions should be undertaken only
when in the judgment of
the physician, the probable benefits outweigh the possible risks.
All patients should wear goggles and should close their eyes during
treatment with UV
light.
PRECAUTIONS
Should be used only by healthy adults, and use solely to produce a
cosmetic tan is not
recommended because of its potential toxicity and uncertain results.
When used to increase
tolerance to sunlight (albinism) and accelerate suntan (people with
very light compl
                                
                                Leer el documento completo
                                
                            

Documentos en otros idiomas

Ficha técnica Ficha técnica francés 27-09-2004

Buscar alertas relacionadas con este producto